Abstract
Objective:
To identify the association between birth weight (BW)-for-gestational age (GA) and pulmonary hypertension (PHTN) at 36 weeks in infants with moderate–severe bronchopulmonary dysplasia (BPD).
Study Design:
In this retrospective cohort study, we followed 138 premature infants (⩽28 weeks) with moderate and severe BPD (National Institutes of Health consensus definition) born at Prentice Women’s Hospital between 2005 and 2009. BW percentiles were calculated using the Fenton growth curve for premature infants. PHTN was determined using a standardized algorithm of echocardiogram review at 36 weeks. Logistic regression was used to evaluate the associations between BW percentile subgroups and PHTN, taking into account antenatal and neonatal factors that were related to PHTN.
Result:
PHTN was associated with small BW-for-GA, ranging from thresholds of <10th to <25th percentile (P<0.001). These associations remained significant when comparing BW <25th percentile to the reference group (50 to 89th percentile); after adjustment for GA, gender, multiple gestation, race/ethnicity (odds ratio (OR)=4.2; 95% confidence interval (CI)=1.5, 12.1); and after further adjustment for maternal vascular disease, intrauterine infection, oligohydramnios and relevant postnatal factors (OR=5.7; 95% CI=1.5, 21.2). Longitudinal follow-up of this cohort showed a trend toward higher morbidity and death among PHTN infants with BW <25th percentile.
Conclusion:
BW-for-GA is an important predictor of PHTN in premature infants with moderate–severe BPD. Our findings contribute to the growing evidence supporting fetal mechanisms of later onset pulmonary vascular disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK et al. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 2010; 40 (3): 131–136.
Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007; 120 (6): 1260–1269.
Slaughter JL, Pakrashi T, Jones DE, South AP, Shah TA . Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation. J Perinatol 2011; 31 (10): 635–640.
Mourani PM, Mullen M, Abman SH . Pulmonary hypertension in bronchopulmonary dysplasia. Prog Pediatr Cardiol 2009; 27 (1-2): 43–48.
Bose C, Van Marter LJ, Laughon M, O’Shea TM, Allred EN, Karna P et al. Fetal growth restriction and chronic lung disease among infants born before the 28th week of gestation. Pediatrics 2009; 124 (3): e450–e458.
Lal MK, Manktelow BN, Draper ES, Field DJ . Chronic lung disease of prematurity and intrauterine growth retardation: a population-based study. Pediatrics 2003; 111 (3): 483–487.
Rozance PJ, Seedorf GJ, Brown A, Roe G, O’Meara MC, Gien J et al. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol 2011; 301 (6): L860–L871.
Rueda-Clausen CF, Morton JS, Davidge ST . Effects of hypoxia-induced intrauterine growth restriction on cardiopulmonary structure and function during adulthood. Cardiovasc Res 2009; 81 (4): 713–722.
Bhat R, Salas AA, Foster C, Carlo WA, Ambalavanan N . Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 2012; 129 (3): e682–e689.
Ehrenkranz RA, Walsh MC, Vohr BR, Jobe AH, Wright LL, Fanaroff AA et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116 (6): 1353–1360.
Denton CP, Cailes JB, Phillips GD, Wells AU, Black CM, Bois RM . Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 1997; 36 (2): 239–243.
Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J 2004; 25 (24): 2243–2278.
Porta N, Wax DF, Lestrud SO, Beier JM, Gotteiner NL . Echocardiographic assessment of ventricular dimensions predict degree of pulmonary hypertension in premature infants with bronchopulmonary dysplasia. Pediat Res 2010 E-PAS2010 3708.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 101: ultrasonography in pregnancy. Obstet Gynecol 2009; 113 (2 Pt 1): 451–461.
Fenton TR . A new growth chart for preterm babies: Babson and Benda’s chart updated with recent data and a new format. BMC Pediatr 2003; 3: 13.
ACOG Committee on Obstetric Practice ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77 (1): 67–75.
Papile LA, Burstein J, Burstein R, Koffler H . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1500 gm. J Pediatr 1978; 92 (4): 529–534.
Walsh MC, Kliegman RM . Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986; 33 (1): 179–201.
Barker DJ . The fetal and infant origins of disease. Eur J Clin Invest 1995; 25 (7): 457–463.
Jayet PY, Rimoldi SF, Stuber T, Salmon CS, Hutter D, Rexhaj E et al. Pulmonary and systemic vascular dysfunction in young offspring of mothers with preeclampsia. Circulation 2010; 122 (5): 488–494.
Kim DH, Kim HS, Choi CW, Kim EK, Kim BI, Choi JH . Risk factors for pulmonary artery hypertension in preterm infants with moderate or severe bronchopulmonary dysplasia. Neonatology 2012; 101 (1): 40–46.
Hoyert DL, Mathews TJ, Menacker F, Strobino DM, Guyer B . Annual summary of vital statistics: 2004. Pediatrics 2006; 117 (1): 168–183.
Zeitlin J, Ancel PY, Saurel-Cubizolles MJ, Papiernik E . The relationship between intrauterine growth restriction and preterm delivery: an empirical approach using data from a European case-control study. Br J Obstet Gynaecol 2000; 107 (6): 750–758.
Zeitlin J, El Ayoubi M, Jarreau PH, Draper ES, Blondel B, Kunzel W et al. Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort. J Pediatr 2010; 157 (5): 733–9 e1.
Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH . Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 2008; 121 (2): 317–325.
Acknowledgements
This project was supported by NHLBI Grant K23 HL093302 (PI: Mestan).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Check, J., Gotteiner, N., Liu, X. et al. Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia. J Perinatol 33, 553–557 (2013). https://doi.org/10.1038/jp.2012.164
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2012.164
Keywords
This article is cited by
-
Quantifying side effects and caregiver burdens of pediatric pulmonary hypertension therapies
BMC Pediatrics (2023)
-
Pharmacokinetics of l-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
Pediatric Drugs (2023)
-
Preventative practices and effects of the COVID-19 pandemic on caregivers of children with pediatric pulmonary hypertension
BMC Public Health (2022)
-
Risk factors and bronchopulmonary dysplasia severity: data from the Spanish Bronchopulmonary Dysplasia Research Network
European Journal of Pediatrics (2022)
-
Patho-mechanisms of the origins of bronchopulmonary dysplasia
Molecular and Cellular Pediatrics (2021)